Reuters logo
BRIEF-GSK announces positive final stage results for two-drug HIV treatment
February 14, 2017 / 7:18 AM / 10 months ago

BRIEF-GSK announces positive final stage results for two-drug HIV treatment

Feb 14 (Reuters) - GlaxoSmithKline Plc :

* VIIV phase III results dolutegravir & rilpivirine

* Announces detailed positive phase III results for investigational two-drug regimen of dolutegravir and rilpivirine for HIV treatment

* In sword studies, two-drug regimen showed comparable efficacy to three- or four-drug regimens in virologically suppressed patients

* Headline results were announced in December 2016

* Use of dolutegravir and rilpivirine as a two-drug regimen for hiv-1 maintenance therapy is investigational and not approved anywhere in world Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below